UnitedHealth Group Inc. (NYSE: UNH) is set to report its most recent quarterly results before the markets open on Wednesday. For the first quarter, analysts are calling for $3.63 in earnings per share (EPS) and $64.33 billion in revenue. In the same period of last year, the managed health care giant said it had $3.73 in EPS and $60.31 billion in revenue.
During the latest quarter, total revenues grew $2.5 billion, or 4.1%, year over year, reflecting balanced, broad-based revenue growth across the businesses.
At that time, UnitedHealthcare revenues increased 4.2% year over year to $48.2 billion. Third-quarter 2019 earnings from operations at UnitedHealthcare grew by 16.7%, driven by revenue growth and strong cost disciplines.
Also, Optum revenues grew by 8.0% year over year to $29.8 billion, and earnings from operations advanced 11.1%.
Here’s what analysts are saying ahead of the report:
- SunTrust Banks has a Buy rating with a $340 price target.
- Barclays has a Buy rating with a $322 price target.
- Morgan Stanley has an Overweight rating with a $281 price target.
- Deutsche Bank has a Buy rating with a $308 price target.
Excluding Tuesday’s move, UnitedHealth had outperformed the broad markets with a pullback of about 10% year to date. In the past 52 weeks, the stock was actually up 12% year to date.
UnitedHealth stock traded up about 3% on Tuesday, at $272.00 in a 52-week range of $187.72 to $306.71. The consensus price target is $318.88.
24/7 Wall St.Buffett Missed These Two…
Warren Buffett loves dividend stocks, and has stuffed Berkshire with some of his favorites.
But he overlooked two dividend legends that continue to print checks on a new level, they’re nowhere in his portfolio.
Unlock the two dividend legends Buffett missed in this new free report.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
